The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

This isn’t just hopeful thinking – it’s a real possibility, thanks to an expanding basket of options that are revolutionising our approach to HIV prevention.

Black women ‘bear the burden’ of new HIV infections, ViiV Healthcare has tool that can help ViiV Healthcare launches new Black women’s health activity books with a star-studded dinner party.

Young people still face high HIV risks despite PrEP Learn why prevention efforts must center Gen Z for a healthier future.

The United States has given its approval to the world’s first twice-a-year injection for HIV prevention, marking a significant step towards a global rollout that could safeguard millions.

Any new HIV prevention method is not meant to sit on the shelf but to be used by the people who need it to protect themselves from HIV. We have to ensure that new HIV prevention technologies that ...

Catherine Falls Commercial/Moment RF/Getty Images via CNN Newsource Phase 3 trial data shows that a twice-yearly injection of the drug lenacapavir can provide total protection against HIV infections.

The development of long-acting PrEP methods makes it a pivotal moment for the global HIV response. Transforming HIV prevention will depend on ensuring a comprehensive set of PrEP options are available ...

We need bold, comprehensive action to make the full range of HIV prevention options available to every woman and girl who needs them. Their lives and futures depend on the actions we take today.

Catherine Falls Commercial/Moment RF/Getty Images via CNN Newsource Phase 3 trial data shows that a twice-yearly injection of the drug lenacapavir can provide total protection against HIV infections.

This isn't just hopeful thinking – it's a real possibility, thanks to an expanding basket of options that are revolutionizing our approach to HIV prevention.